PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Graeber, M.D.
Galderma R&D, LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rady Children'S Hospital - Pediatric and Adolescent Dermatology
San Diego, California, United States
- Dawes Fretzin Clinical Research Group, Llc
Indianapolis, Indiana, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- University of North Carolina Dermatology and Skin Cancer Center
Chapel Hill, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Menter Dermatology Research Institute
Dallas, Texas, United States
- Clinical Trials of Texas, Inc.
San Antonio, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2013
- Primary completion
- 30 Nov 2015
- Completion
- 30 Nov 2015
- Last update posted
- 18 Feb 2021
- Registered enrollment
- 18
- Registry id
- NCT01766440
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.